[{"AccountsPayableCurrent_0_Q1_USD":636000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":14000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":3348000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-5327000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":243000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":8684000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":229000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":8.79,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":120678.0,"OtherLiabilitiesCurrent_0_Q1_USD":213000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":4158000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":1302000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":52.28,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":14.22,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":31.71,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":548193.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":21.28,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1_Q1_shares":84444.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":76000.0,"OtherAssetsNoncurrent_0_Q1_USD":1505000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":539000.0,"IncreaseDecreaseInPrepaidRent_1_Q1_USD":2400000.0,"AccruedIncomeTaxes_0_Q1_USD":50000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":2633000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":2701000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":509000.0,"OperatingLeaseLiability_0_Q1_USD":3210000.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":1021000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":513000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":1358000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":1385000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":1413000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":1441000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":11316000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":17426000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":262000.0,"FinanceLeaseRightOfUseAssetAmortization_1_Q1_USD":26000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":186700000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":6479000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":24000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":539000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":11445000.0,"LeaseAndRentalExpense_1_Q1_USD":178000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":1181000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":17129.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":243000.0,"LiabilitiesCurrent_0_Q1_USD":4061000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":205131000.0,"Liabilities_0_Q1_USD":6762000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-108000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":244000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":2421000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.31,"Depreciation_1_Q1_USD":335000.0,"CommonStockValue_0_Q1_USD":0.0,"CommonStockSharesOutstanding_0_Q1_shares":17370564.0,"CommonStockSharesIssued_0_Q1_shares":17370564.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_1_Q1_USD":-7289000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":180225000.0,"AssetsCurrent_0_Q1_USD":188329000.0,"Assets_0_Q1_USD":205131000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":548193.0,"AdditionalPaidInCapital_0_Q1_USD":242733000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":24000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-1305000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":1967000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-6227000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1508000.0,"ShareBasedCompensation_1_Q1_USD":539000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":3525000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":2061773.0,"PreferredStockSharesAuthorized_0_Q1_shares":20000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0,"OperatingIncomeLoss_1_Q1_USD":-5946000.0,"OperatingExpenses_1_Q1_USD":5946000.0,"CommonStockSharesAuthorized_0_Q1_shares":80000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q1_USD":2916000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":17359356.0,"StockholdersEquity_0_Q1_USD":198369000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-44388000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":10264000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":243000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":1625000.0,"NetIncomeLoss_1_Q1_USD":-5341000.0,"ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_1_Q1_USD":2170000.0,"Ticker":"KRYS","CIK":"1711279","name":"KRYSTAL BIOTECH, INC.","OfficialName":"Krystal Biotech Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1834745088.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200504"}]